NCT01598818 is a clinical trial in Vision Loss, sponsored by University of Nebraska.

Who is sponsoring NCT01598818?

NCT01598818 is sponsored by University of Nebraska.

What condition does NCT01598818 study?

NCT01598818 studies Vision Loss.

Is NCT01598818 still recruiting?

NCT01598818 is currently completed. Last updated 1 September 2023.

Last reviewed 2023-09-01 · How we verify

NCT01598818

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

First-Sight Refractive Error Correction in the Developing World

Completed Last updated 1 September 2023

What this trial tests

trial in Vision Loss in 150 participants. Completed in 13 January 2014.

Timeline

11 May 2012

Primary endpoint
13 January 2014

13 January 2014

Quick facts

Lead sponsor	University of Nebraska
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	11 May 2012
Primary completion	13 January 2014
Estimated completion	13 January 2014
Sites	2 locations across Haiti, United States

Conditions studied

Vision Loss — all drugs for Vision Loss →

Sponsor

University of Nebraska

Who can join

Adults 7 to 50, any sex, with Vision Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to test the efficacy of the First-Sight refractive kit designed to provide refractive correction of simple hyperopia, myopia and astigmatism with autorefraction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01598818 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 1 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01598818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing